Desktop Site |
18 Apr 24 | 15:15 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote  
Notices |
 
S&P BSE SENSEX 72,641.71 -301.97 -0.41 %
Corporate Announcement
  • Security Code524804
    CompanyAurobindo Pharma Ltd
    Exchange Received Time19/02/2020 08:46:00
    Exchange Disseminated Time19/02/2020 08:46:07
    Time Taken00:00:07
     
     
     Update On US FDA Inspection At Our Unit IV - Reg., | 2/19/2020 8:46:01 AM 
     Further to our intimation dated November 13, 2019 with regard to the USFDA inspection of Unit IV, a general injectable formulation manufacturing facility of the Company, we would like to inform you that the Company has received the Establishment Inspection Report (EIR) with Voluntary Action Initiated (VAI) status from USFDA.

    Please take the above information on record.
    		 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(20H) 18 Apr 24|15:15 (IST)